MXPA02009316A - Formulacion de tabletas de oxazolidinona. - Google Patents

Formulacion de tabletas de oxazolidinona.

Info

Publication number
MXPA02009316A
MXPA02009316A MXPA02009316A MXPA02009316A MXPA02009316A MX PA02009316 A MXPA02009316 A MX PA02009316A MX PA02009316 A MXPA02009316 A MX PA02009316A MX PA02009316 A MXPA02009316 A MX PA02009316A MX PA02009316 A MXPA02009316 A MX PA02009316A
Authority
MX
Mexico
Prior art keywords
oxazolidinone
tablet formulation
provides
present
compressed tablet
Prior art date
Application number
MXPA02009316A
Other languages
English (en)
Inventor
Homer Lin
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22703542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA02009316(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MXPA02009316A publication Critical patent/MXPA02009316A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La presente invencion proporciona una tableta comprimida de un agente antibacteriano de oxazolidinona que provee una alta carga de farmaco y una excelente biodisponibilidad.
MXPA02009316A 2000-03-22 2001-03-15 Formulacion de tabletas de oxazolidinona. MXPA02009316A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19096900P 2000-03-22 2000-03-22
PCT/US2001/005812 WO2001070225A2 (en) 2000-03-22 2001-03-15 Oxazolidinone tablet formulation

Publications (1)

Publication Number Publication Date
MXPA02009316A true MXPA02009316A (es) 2004-04-05

Family

ID=22703542

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02009316A MXPA02009316A (es) 2000-03-22 2001-03-15 Formulacion de tabletas de oxazolidinona.

Country Status (33)

Country Link
EP (1) EP1265608B1 (es)
JP (1) JP2003527424A (es)
KR (2) KR20070094673A (es)
CN (1) CN1208058C (es)
AR (1) AR033357A1 (es)
AT (1) ATE412413T1 (es)
AU (2) AU4324301A (es)
BG (1) BG107117A (es)
BR (1) BR0108846A (es)
CA (1) CA2400118A1 (es)
CZ (1) CZ20023133A3 (es)
DE (1) DE60136341D1 (es)
DK (1) DK1265608T3 (es)
EA (1) EA006772B1 (es)
EC (1) ECSP013979A (es)
ES (1) ES2312422T3 (es)
HK (1) HK1054325B (es)
HR (1) HRP20020765A2 (es)
HU (1) HUP0300378A3 (es)
IL (1) IL151788A0 (es)
MX (1) MXPA02009316A (es)
MY (1) MY136370A (es)
NO (1) NO20024505D0 (es)
NZ (1) NZ521525A (es)
PE (2) PE20011126A1 (es)
PL (1) PL201686B1 (es)
PT (1) PT1265608E (es)
SK (1) SK12092002A3 (es)
TW (1) TWI293028B (es)
UA (1) UA77654C2 (es)
WO (1) WO2001070225A2 (es)
YU (1) YU69802A (es)
ZA (1) ZA200207073B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
DK1749517T3 (da) * 2005-07-20 2008-11-03 Teva Pharma Stabil farmaceutiske sammensætning af linezolid form IV
WO2010026597A1 (en) * 2008-09-02 2010-03-11 Hetero Research Foundation Oral dosage forms of linezolid and processes for their preparation
CA2818249C (en) * 2010-11-24 2021-04-13 Rib-X Pharmaceuticals, Inc. Pharmaceutical compositions comprising radezolid, hydroxypropylmethyl cellulose polymer, and a physical mixture
WO2013088389A1 (en) * 2011-12-14 2013-06-20 Alembic Pharmaceuticals Limited Linezolid premix
CN103505459B (zh) * 2012-06-20 2016-02-24 北京万生药业有限责任公司 利奈唑胺药物组合物
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
PT3277270T (pt) 2015-04-01 2021-12-07 Akebia Therapeutics Inc Composições e métodos de tratamento de anemia
CN106727396A (zh) * 2016-11-22 2017-05-31 湖北广济药业股份有限公司 一种ⅱ晶型利奈唑胺片及其制备方法
CN109481412A (zh) * 2018-08-17 2019-03-19 扬子江药业集团北京海燕药业有限公司 一种ii晶型利奈唑胺片及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993767A (en) * 1975-11-18 1976-11-23 A. H. Robins Company, Incorporated Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy
AUPP437698A0 (en) * 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
BR0010982A (pt) * 1999-05-27 2002-03-05 Upjohn Co Novas oxazolidinonas bicìclicas como agentes antibacterianos

Also Published As

Publication number Publication date
AU2001243243B2 (en) 2004-10-14
KR100786410B1 (ko) 2007-12-17
AR033357A1 (es) 2003-12-17
ES2312422T3 (es) 2009-03-01
HK1054325B (zh) 2006-01-13
SK12092002A3 (sk) 2002-12-03
HK1054325A1 (en) 2003-11-28
YU69802A (sh) 2005-11-28
AU4324301A (en) 2001-10-03
PT1265608E (pt) 2008-12-15
HUP0300378A3 (en) 2004-11-29
NZ521525A (en) 2004-02-27
BG107117A (bg) 2003-05-30
CN1208058C (zh) 2005-06-29
KR20020083185A (ko) 2002-11-01
PL366067A1 (en) 2005-01-24
ECSP013979A (es) 2002-01-25
CA2400118A1 (en) 2001-09-27
PE20020499Z (es) 2002-07-12
TWI293028B (en) 2008-02-01
KR20070094673A (ko) 2007-09-20
NO20024505L (no) 2002-09-20
CN1418097A (zh) 2003-05-14
EP1265608A2 (en) 2002-12-18
PL201686B1 (pl) 2009-04-30
DE60136341D1 (de) 2008-12-11
CZ20023133A3 (cs) 2003-01-15
IL151788A0 (en) 2003-04-10
EA200201006A1 (ru) 2003-02-27
EA006772B1 (ru) 2006-04-28
BR0108846A (pt) 2003-05-06
ZA200207073B (en) 2003-12-03
JP2003527424A (ja) 2003-09-16
HRP20020765A2 (en) 2003-12-31
WO2001070225A2 (en) 2001-09-27
NO20024505D0 (no) 2002-09-20
MY136370A (en) 2008-09-30
HUP0300378A2 (hu) 2003-06-28
ATE412413T1 (de) 2008-11-15
PE20011126A1 (es) 2001-10-31
EP1265608B1 (en) 2008-10-29
UA77654C2 (en) 2007-01-15
WO2001070225A3 (en) 2001-12-13
DK1265608T3 (da) 2008-12-08

Similar Documents

Publication Publication Date Title
IL157771A0 (en) Intravaginal drug delivery devices for the administration of an antimicrobial agent
MXPA03006884A (es) Formulacion farmaceutica.
EP1499300A4 (en) PHARMACEUTICAL FORMULATIONS WITH IMPROVED BIOAVAILABILITY
IL157741A0 (en) Pharmaceutical compositions containing an antihyperplastic active agent
IL155992A0 (en) Pharmaceutical compositions for the oral delivery of pharmacologically active agents
MXPA03007641A (es) Formulacion farmaceutica.
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
HK1073253A1 (en) High drug load tablet
PL356904A1 (en) Pharmaceutical compositions
GB0128277D0 (en) Pharmaceutical compositions
MXPA03010761A (es) Combinaciones farmaceuticas.
HUP0201591A3 (en) Pharmaceutical formulations comprising an hiv protease inhibitor
YU69802A (sh) Formulacija oksazolidinon tablete
RS97604A (en) New etonogestrel esters
IL162325A0 (en) Hiv integrase inhibitor compounds and pharmaceutical compositions containing the same
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
EP1448170A4 (en) EFAVIRENZ STAMP PREPARATIONS HAVING UNIQUE BIOPHARMACEUTICAL CHARACTERISTICS
HUP0303860A3 (en) A pharmaceutical tablet having a high active ingredient
ZA200402729B (en) Pharmaceutical formulation comprising (R) -bicalutamide.
MY135452A (en) 2-methyl-thieno-benzodiazepine lyophilized formulation
CA101081S (en) Table base caster
TW200631607A (en) Oral drug delivery system
UA59085C2 (en) Tableted drug containing ranitidine
AU2002304093A1 (en) Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient
PL370709A1 (en) Pharmaceutical formulation comprising cyclosporin and use thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal